DeepMed Research

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity

Phase 1

Completed

Conditions: Obesity

Interventions: Drug: Danuglipron

First Posted Date: 2024-08-23

Last Posted Date: 2025-01-20

Lead Sponsor: Pfizer

Target Recruit Count: 23

Registration Number: NCT06568731

Locations: 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

Phase 1

Active, not recruiting

Conditions: Obesity

Interventions: Drug: Danuglipron
Drug: Atorvastatin
Drug: Rosuvastatin

First Posted Date: 2024-08-22

Last Posted Date: 2025-03-28

Lead Sponsor: Pfizer

Target Recruit Count: 82

Registration Number: NCT06567327

Locations: 🇺🇸
Qps - Mra, Llc., South Miami, Florida, United States
🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸
Qps-Mra, Llc, South Miami, Florida, United States

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Phase 1

Recruiting

Conditions: Healthy Participants
Atopic Dermatitis

Interventions: Other: Placebo
Drug: PF-07832837

First Posted Date: 2024-08-21

Last Posted Date: 2025-05-13

Lead Sponsor: Pfizer

Target Recruit Count: 143

Registration Number: NCT06564389

Locations: 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Phase 3

Recruiting

Conditions: Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Interventions: Drug: PF-06821497
Drug: Docetaxel
Drug: Enzalutamide

First Posted Date: 2024-08-13

Last Posted Date: 2025-05-20

Lead Sponsor: Pfizer

Target Recruit Count: 600

Registration Number: NCT06551324

Locations: 🇺🇸
Urology Centers of Alabama, Homewood, Alabama, United States
🇺🇸
Arizona Urology Specialists- Provide ICF for Review Only, Tucson, Arizona, United States
🇺🇸
Arizona Urology Specialists (AUS)-Orange Grove, Tucson, Arizona, United States

and more 161 locations

A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Phase 1

Active, not recruiting

Conditions: Colorectal Carcinoma
Squamous Cell Carcinoma of the Head and Neck
Renal Cell Carcinoma
Ovarian Carcinoma
Neoplasms
Non-small-cell Lung Cancer

Interventions: Drug: PF-07826390
Biological: sasanlimab
Other: SOC (anti-PD-1 + platinum -based chemo)

First Posted Date: 2024-08-09

Last Posted Date: 2025-04-06

Lead Sponsor: Pfizer

Target Recruit Count: 5

Registration Number: NCT06546553

Locations: 🇺🇸
START Midwest, Grand Rapids, Michigan, United States
🇺🇸
Thomas Jefferson University Honickman Center, Philadelphia, Pennsylvania, United States
🇺🇸
Thomas Jefferson University, Bodine Center for Radiation Therapy, Philadelphia, Pennsylvania, United States

and more 8 locations

SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER

Not yet recruiting

Conditions: Respiratory Syncytial Virus Infection

Interventions: Biological: RSVpreF vaccine

First Posted Date: 2024-08-09

Last Posted Date: 2025-04-11

Lead Sponsor: Pfizer

Target Recruit Count: 1100

Registration Number: NCT06546800

Locations: 🇯🇵
Pfizer, Tokyo, Japan

A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.

Phase 1

Active, not recruiting

Conditions: Healthy

Interventions: Drug: Danuglipron
Drug: Cyclosporine
Drug: Itraconazole

First Posted Date: 2024-08-07

Last Posted Date: 2025-03-28

Lead Sponsor: Pfizer

Target Recruit Count: 16

Registration Number: NCT06541678

Locations: 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

A Study to Learn About How a New Pneumococcal Vaccine Works in Children

Phase 2

Recruiting

Conditions: Pneumococcal Disease

Interventions: Biological: PG4
Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)

First Posted Date: 2024-08-01

Last Posted Date: 2024-12-04

Lead Sponsor: Pfizer

Target Recruit Count: 300

Registration Number: NCT06531538

Locations: 🇺🇸
Bluegrass Clinical Research, Inc., Louisville, Kentucky, United States
🇺🇸
Bio-Medical Research LLC, Miami, Florida, United States
🇺🇸
Tekton Research, LLC., Beaumont, Texas, United States

and more 41 locations

A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.

Completed

Conditions: Migraine

First Posted Date: 2024-08-01

Last Posted Date: 2024-08-01

Lead Sponsor: Pfizer

Target Recruit Count: 1

Registration Number: NCT06532357

Locations: 🇺🇸
Pfizer, New York, New York, United States

A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.

Phase 1

Active, not recruiting

Conditions: Healthy

Interventions: Drug: PF-07940369
Drug: Placebo

First Posted Date: 2024-08-01

Last Posted Date: 2024-11-04

Lead Sponsor: Pfizer

Target Recruit Count: 18

Registration Number: NCT06532383

Locations: 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy